Found: 99
Select item for more details and to access through your institution.
Validation of a deep learning segmentation algorithm to quantify the skeletal muscle index and sarcopenia in metastatic renal carcinoma.
- Published in:
- European Radiology, 2022, v. 32, n. 7, p. 4728, doi. 10.1007/s00330-022-08579-9
- By:
- Publication type:
- Article
Practical aspects of metastatic castration-resistant prostate cancer management: patient case studies.
- Published in:
- BJU International, 2012, v. 109, p. 14, doi. 10.1111/j.1464-410X.2011.10872.x
- By:
- Publication type:
- Article
Advances in the management of high-risk localised and metastatic prostate cancer.
- Published in:
- BJU International, 2012, v. 109, p. 8, doi. 10.1111/j.1464-410X.2011.10871.x
- By:
- Publication type:
- Article
The use of estramustine phosphate in the modern management of advanced prostate cancer.
- Published in:
- BJU International, 2011, v. 108, n. 11, p. 1782, doi. 10.1111/j.1464-410X.2011.10201.x
- By:
- Publication type:
- Article
Current and emerging treatment modalities for metastatic castration-resistant prostate cancer.
- Published in:
- BJU International, 2011, v. 107, p. 13, doi. 10.1111/j.1464-410X.2010.10036.x
- By:
- Publication type:
- Article
Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre study.
- Published in:
- BJU International, 2010, v. 106, n. 7, p. 974, doi. 10.1111/j.1464-410X.2010.09296.x
- By:
- Publication type:
- Article
Optimal management of metastatic renal cell carcinoma: an algorithm for treatment.
- Published in:
- BJU International, 2009, v. 104, n. 1, p. 10, doi. 10.1111/j.1464-410X.2009.08563.x
- By:
- Publication type:
- Article
What is the real impact of bone pain on survival in patients with metastatic hormone-refractory prostate cancer treated with docetaxel?
- Published in:
- BJU International, 2009, v. 103, n. 12, p. 1641, doi. 10.1111/j.1464-410X.2008.08283.x
- By:
- Publication type:
- Article
Prostate-specific antigen kinetics in localized and advanced prostate cancer.
- Published in:
- BJU International, 2009, v. 103, n. 5, p. 578, doi. 10.1111/j.1464-410X.2009.08345.x
- By:
- Publication type:
- Article
The medical management of prostate cancer: a multidisciplinary team approach.
- Published in:
- BJU International, 2007, v. 99, n. 1, p. 22, doi. 10.1111/j.1464-410X.2006.06477.x
- By:
- Publication type:
- Article
Neoadjuvant Dose-Dense Gemcitabine plus Docetaxel and Vinorelbine plus Epirubicin for Operable Breast Cancer.
- Published in:
- Drugs in R&D, 2011, v. 11, n. 2, p. 147, doi. 10.2165/11591210-000000000-00000
- By:
- Publication type:
- Article
Impact of First Line Antiangiogenic Therapy Duration on Nivolumab Outcome in Metastatic Renal Cell Carcinoma Patients Treated in the GETUG--AFU 26 NIVOREN.
- Published in:
- Clinical Genitourinary Cancer, 2023, v. 21, n. 6, p. 643, doi. 10.1016/j.clgc.2023.07.008
- By:
- Publication type:
- Article
Taxanes Versus Androgen Receptor Therapy as Second-Line Treatment for Castrate-Resistant Metastatic Prostate Cancer After First-Line Androgen Receptor Therapy.
- Published in:
- Clinical Genitourinary Cancer, 2023, v. 21, n. 3, p. 349, doi. 10.1016/j.clgc.2023.02.006
- By:
- Publication type:
- Article
Efficacy and Safety of Concomitant Proton Pump Inhibitor and Nivolumab in Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study.
- Published in:
- Clinical Genitourinary Cancer, 2022, v. 20, n. 5, p. 488, doi. 10.1016/j.clgc.2022.07.003
- By:
- Publication type:
- Article
Cost-effectiveness Analysis of Innovative Therapy for Patients with Newly Diagnosed Hormone-Sensitive Metastatic Prostate Cancer.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 5, p. e326, doi. 10.1016/j.clgc.2021.03.022
- By:
- Publication type:
- Article
Drug Management of Prostate Cancer: Prevalence and Consequences of Renal Insufficiency.
- Published in:
- Clinical Genitourinary Cancer, 2009, v. 7, n. 3, p. E83, doi. 10.3816/CGC.2009.n.029
- By:
- Publication type:
- Article
MiTF/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular Insights.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 14, p. 7649, doi. 10.3390/ijms23147649
- By:
- Publication type:
- Article
Supportive Care Organization in France: a national in-depth survey among patients and oncologists.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Comment faire progresser les connaissances sur la toxicité des immunothérapies en 2024 ?
- Published in:
- Revue Immunité & Cancer, 2023, v. 7, n. 4, p. 159
- By:
- Publication type:
- Article
Carcinomes rénaux à cellules chromophobes – Quelle place pour les traitements systémiques ?
- Published in:
- Revue Immunité & Cancer, 2022, v. 6, n. 4, p. 177
- By:
- Publication type:
- Article
Mitochondria-bound hexokinase as target for therapy of malignant gliomas.
- Published in:
- International Journal of Cancer, 1995, v. 62, n. 2, p. 216, doi. 10.1002/ijc.2910620218
- By:
- Publication type:
- Article
Neutropenia, neutrophilia, and neutrophil–lymphocyte ratio as prognostic markers in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221100022
- By:
- Publication type:
- Article
Tim-3: Biomarqueur et cible thérapeutique en cancérologie.
- Published in:
- Médecine Sciences, 2018, v. 34, n. 3, p. 231, doi. 10.1051/medsci/20183403011
- By:
- Publication type:
- Article
Signification et intérêt clinique de l'expression de PD-1 et PDL-1 dans les tumeurs.
- Published in:
- Médecine Sciences, 2013, v. 29, n. 6/7, p. 570, doi. 10.1051/medsci/2013296005
- By:
- Publication type:
- Article
Sustained response to vemurafenib in a low grade serous ovarian cancer with a BRAF V600E mutation.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 6, p. 1267, doi. 10.1007/s10637-015-0297-4
- By:
- Publication type:
- Article
A novel VCP::TFE3 gene fusion resulting from t(X;9)(p11.23;p13.3) chromosome translocation in TFE3 rearranged renal cancer cell carcinoma.
- Published in:
- Genes, Chromosomes & Cancer, 2023, v. 62, n. 6, p. 361, doi. 10.1002/gcc.23127
- By:
- Publication type:
- Article
Biomarkers from the tumor microenvironment to predict clinical response to checkpoint inhibitors.
- Published in:
- Journal of OncoPathology, 2014, v. 2, n. 4, p. 117, doi. 10.13032/tjop.2052-5931.100111.
- By:
- Publication type:
- Article
High Milk Consumption Does Not Affect Prostate Tumor Progression in Two Mouse Models of Benign and Neoplastic Lesions.
- Published in:
- PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0125423
- By:
- Publication type:
- Article
Risk of Hormone Escape in a Human Prostate Cancer Model Depends on Therapy Modalities and Can Be Reduced by Tyrosine Kinase Inhibitors.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0042252
- By:
- Publication type:
- Article
Update on the most promising biomarkers of response to immune checkpoint inhibitors in clear cell renal cell carcinoma.
- Published in:
- World Journal of Urology, 2021, v. 39, n. 5, p. 1377, doi. 10.1007/s00345-020-03528-x
- By:
- Publication type:
- Article
Clinical recommendations in the management of advanced prostate cancer: International Gastrointestinal, Liver and Uro-oncology (IGILUC 2019) experts.
- Published in:
- World Journal of Urology, 2021, v. 39, n. 5, p. 1421, doi. 10.1007/s00345-020-03328-3
- By:
- Publication type:
- Article
A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 261, doi. 10.1007/s00262-010-0935-9
- By:
- Publication type:
- Article
Lung Cancer and Renal Insufficiency: Prevalence and Anticancer Drug Issues.
- Published in:
- Lung, 2009, v. 187, n. 1, p. 69, doi. 10.1007/s00408-008-9123-5
- By:
- Publication type:
- Article
Renal Carcinoma and Angiogenesis: Therapeutic Target and Biomarkers of Response in Current Therapies.
- Published in:
- Cancers, 2022, v. 14, n. 24, p. 6167, doi. 10.3390/cancers14246167
- By:
- Publication type:
- Article
Metastatic Renal Medullary and Collecting Duct Carcinoma in the Era of Antiangiogenic and Immune Checkpoint Inhibitors: A Multicentric Retrospective Study.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1678, doi. 10.3390/cancers14071678
- By:
- Publication type:
- Article
Pain Progression at Initiation of Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Post Hoc Analysis of the PROSELICA Study.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1284, doi. 10.3390/cancers13061284
- By:
- Publication type:
- Article
Enhance the Immune Checkpoint Inhibitors Efficacy with Radiotherapy Induced Immunogenic Cell Death: A Comprehensive Review and Latest Developments.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 678, doi. 10.3390/cancers13040678
- By:
- Publication type:
- Article
Tumor Microenvironment Features as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors (ICI) in Metastatic Clear Cell Renal Cell Carcinoma (mccRCC).
- Published in:
- Cancers, 2021, v. 13, n. 2, p. 231, doi. 10.3390/cancers13020231
- By:
- Publication type:
- Article
Comparative Efficacy of First-Line Immune-Based Combination Therapies in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1673, doi. 10.3390/cancers12061673
- By:
- Publication type:
- Article
Antiangiogenic therapy for advanced renal cell carcinoma: Management of treatment-related toxicities.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 5, p. 2066, doi. 10.1007/s10637-012-9796-8
- By:
- Publication type:
- Article
Prevalence of renal insufficiency in breast cancer patients and related pharmacological issues.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 124, n. 3, p. 745, doi. 10.1007/s10549-008-0131-1
- By:
- Publication type:
- Article
Cabazitaxel multiple rechallenges in metastatic castration‐resistant prostate cancer.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 18, p. 6304, doi. 10.1002/cam4.4172
- By:
- Publication type:
- Article
Treatments Outcomes in Histological Variants and Non-Urothelial Bladder Cancer: Results of a Multicenter Retrospective Study.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.671969
- By:
- Publication type:
- Article
Mutations in OGG1, a gene involved in the repair of oxidative DNA damage, are found in human lung and kidney tumours.
- Published in:
- Oncogene, 1998, v. 16, n. 23, p. 3083, doi. 10.1038/sj.onc.1202096
- By:
- Publication type:
- Article
Cabozantinib‐nivolumab sequence in metastatic renal cell carcinoma: The CABIR study.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 8, p. 1335, doi. 10.1002/ijc.34126
- By:
- Publication type:
- Article
Matched Case-Control Phase 2 Study to Evaluate the Use of a Frozen Sock to Prevent Docetaxel-lnduced Onycholysis and Cutaneous Toxicity of the Foot.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 7, p. 1625, doi. 10.1002/cncr.23333
- By:
- Publication type:
- Article
Prevalence of Renal Insufficiency in Cancer Patients and Implications for Anticancer Drug Management.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 6, p. 1376, doi. 10.1002/cncr.22904
- By:
- Publication type:
- Article
Phase II trial evaluating a docetaxel-capecitabine combination as treatment for hormone-refractory prostate cancer.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 4, p. 738, doi. 10.1002/cncr.22070
- By:
- Publication type:
- Article
Treatment of patients with advanced or bulky Hodgkin disease with a 12-week doxorubicin, bleomycin, vinblastine, and dacarbazine-like chemotherapy regimen followed by extended-field, full-dose radiotherapy.
- Published in:
- Cancer (0008543X), 2002, v. 95, n. 10, p. 2169, doi. 10.1002/cncr.10932
- By:
- Publication type:
- Article
Hormone escape is associated with genomic instability in a human prostate cancer model.
- Published in:
- International Journal of Cancer, 2009, v. 124, n. 5, p. 1103, doi. 10.1002/ijc.24073
- By:
- Publication type:
- Article